Hims & Hers Q2 Loss Misses Estimates Despite Revenue Beat as Transition Pressures Persist

What happened

Hims & Hers reported a Q2 loss of $0.10 per share, missing the Zacks consensus estimate of a $0.07 loss, while revenue topped estimates—signaling that the branded GLP-1 transition continues to weigh on earnings. The prior Q1 2026 had already shown U.S. revenue down 8%, gross margin falling to 65%, and adjusted EBITDA margin dropping to 7%, and the Q2 bottom-line miss suggests that margin recovery is not yet materializing. The top-line beat likely reflects international growth and subscriber additions, but it has not translated into earnings power as higher product costs and marketing spend persist. FTC litigation and regulatory scrutiny add an overhang, threatening to raise customer acquisition costs and churn if remedies are imposed. With the stock trading near $31, the market seems to price a successful pivot, but Q2 fails to confirm that thesis, leaving risk/reward unattractive.

Implication

The Q2 loss, despite revenue beats, reinforces our WAIT rating. While revenue growth shows platform resilience, the persistent earnings pressure and unresolved FTC overhang mean the stock's current multiple bakes in a best-case scenario. Investors should wait for evidence of U.S. revenue reacceleration, gross margin above 65%, and clarity on regulatory outcomes before considering entry near $24, not $31.

Thesis delta

The Q2 results provide a modest positive signal on top-line momentum but no evidence of margin recovery, leaving the bearish tilt intact. The branded GLP-1 transition remains unproven, and the EPS miss underscores that higher costs are not being offset by revenue growth. No upgrade is warranted until U.S. core economics improve, keeping our WAIT rating and attractive entry at $24 intact.